Day: March 14, 2022

TAMPA, Fla., March 14, 2022 (GLOBE NEWSWIRE) — The board of directors of HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners insurance, with additional operations in reinsurance, real estate and information technology, has authorized a plan to repurchase up to $20 million of the company’s common shares during 2022, subject to market conditions. The plan permits the company to periodically repurchase shares for cash in open market purchases, block transactions and privately negotiated transactions in accordance with applicable federal securities laws. Moreover, the share repurchase plan may be modified, suspended, terminated or extended by the company any time without prior notice. About HCI Group, Inc.HCI Group, Inc. owns subsidiaries engaged in diverse, yet complementary business activities, including...

SAN CLEMENTE, Calif., March 14, 2022 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 8:15 a.m. PT (11:15 a.m. ET) on Tuesday, March 22, 2022. Company management will also be participating in one-on-one meetings on Tuesday, March 22, 2022. The fireside chat will be webcast live and can be accessed by going to the company’s website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay. About ICU Medical, Inc. ICU Medical (Nasdaq:ICUI) is a global leader in infusion systems, infusion consumables, and high-value critical...

NORWALK, Conn., March 14, 2022 (GLOBE NEWSWIRE) — Reed’s, Inc.® (NASDAQ:REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, all-natural ginger beverages, today announced the closing of its previously announced private placement with certain institutional and accredited investors of 18,594,571 shares of common stock and warrants to purchase up to an aggregate of 9,297,289 shares of common stock, for an aggregate gross proceeds of $5.4 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. Officers and directors of the Company purchased approximately $1.1 million of the securities in the offering. The purchase price per share of common stock and associated warrant was $0.28 for the investors (other than officers and directors of the Company)...

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading global analytics and digital solutions company, announced today that it has been named a Leader and Star Performer in Everest Group’s Healthcare Payer Operations PEAK Matrix® Assessment 2022. EXL advanced to a Leader from the Major Contender category in last year’s PEAK MATRIX® Assessment, reflecting the company’s continued growth in analytics and digital solutions, and its commitment to helping clients make sense of data to drive their businesses forward. Everest Group cites EXL’s strong analytics capabilities and domain knowledge as its greatest strengths. “After a brief pause due to the COVID-19 pandemic, the healthcare payer market is again witnessing investments by enterprises in digital technologies, such as analytics and cognitive automation, especially...

DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continue SAN DIEGO, March 14, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced that on March 11, 2022, the Data Safety Monitoring Board (DSMB) overseeing the Phase 2/3 clinical trial investigating the use of Tempol for the treatment of COVID-19, met to evaluate the clinical and safety data from the first planned interim analysis. Following their evaluation, the DSMB recommended that the study continue without modification. “We continue to be pleased with the conduct of the trial and look forward to the next DSMB meeting currently planned for May,” said Dr. Dennis J. Carlo, President and Chief Executive Officer of Adamis Pharmaceuticals. About the Phase 2/3 Clinical Trial Additional information about the trial...

RENO, Nev., March 14, 2022 (GLOBE NEWSWIRE) — Allegiant Gold Ltd. (“Allegiant” or the “Company”) (AUAU: TSX-V) (AUXXF: OTCQX) is pleased to announce a C$4,014,404 financing and strategic investment by Kinross Gold Corporation (“Kinross”) (NYSE: KGC, TSX: K) which will accelerate the exploration and development activities at the Eastside property in Nevada. On closing Kinross will own 9.9% of the then issued shares of Allegiant. Kinross operates the Round Mountain gold mine, located across the valley from Allegiant’s Eastside project. Round Mountain is one of the largest open pit gold mines in the United States. Peter Gianulis, CEO of Allegiant Gold, commented: “We are very excited to have Kinross as a strategic partner, given their experience and prominent presence in Nevada, and the relative close proximity of their flagship Round...

Publicis Groupe Named Ad Age’s First-Ever Holding Company of the Year Publicis Groupe Earns Inaugural Holding Company Designation within A-List & Creativity Awards Additionally Awarded Across Agency & Leadership Categories March 14, 2022 – Publicis Groupe [Euronext Paris: FR0000130577, CAC 40] has been honored as Ad Age’s Holding Company of the Year in the publication’s annual A-List and Creativity Awards. 2022 marks the first year that Ad Age has included a Holding Company category in its awards program. The Ad Age A-List & Creativity Awards recognizes “forward-thinking leaders, top agencies and creative innovators” who pursue “game-changing creativity, bold leadership and have helped point the industry in new directions.” This honor complements additional recognition for several Publicis Groupe agencies across...

Earnings Call Scheduled for 8:00 am U.S. Eastern Time on March 29, 2022 Tokyo, Japan, March 14, 2022 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, as well as other products in Japan, today announced that it will release its unaudited financial results for the first six months of fiscal year 2022 before the U.S. market opens on Tuesday, March 29, 2022. The Company will host an earnings conference call to discuss its financial results at 8:00 am U.S. Eastern Time (9:00 pm Japan Standard Time) on March 29, 2022. To attend this earnings conference call, please use the information below for dial-in access.Dial-in details for the conference call are as follows:Date: March 29, 2022Time: 8:00 am U.S. Eastern TimeInternational: 1-412-902-4272United...

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) — The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), a explorer of lower-impact battery metals from seafloor polymetallic nodules, today announced that it will host a conference call on Thursday, March 24, 2022, to provide an update on fourth quarter financial results. Fourth Quarter 2021 Conference Call DetailsDate: Thursday, March 24, 2022Time: 04:30 p.m. Eastern Daylight Time   Virtual webcast Register Here   Toll-free dial-in number: (844) 200-6205International dial-in number: (929) 526-1599Conference ID: 060819Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations...